Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acyl-protected hydroxylamines as spin label generators for EPR brain imaging.

Alexander T Yordanov1, Ken-ichi Yamada, Murali C Krishna

  • 1Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. yordanov@mail.nih.gov

Journal of Medicinal Chemistry
|May 17, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.

Epilepsia·2026
Same author

Designing and Implementing a Metaverse Strategy for Fall Prevention in Older Adults: A Theoretical Review.

Journal of clinical medicine·2025
Same author

Lennox-Gastaut syndrome unveiled: Advancing diagnosis, therapies, and advocacy-insights from the Genoa International Workshop.

Epilepsia·2025
Same author

Electron paramagnetic resonance imaging to detect acute kidney injury.

American journal of physiology. Renal physiology·2025
Same author

Oncological and functional outcomes of salvage surgery for local oropharyngeal cancer recurrence after primary Radiation±Chemotherapy.

Surgical oncology·2025
Same author

Development and Adaptive Function in Individuals With <i>SCN2A</i>-Related Disorders.

Neurology·2025

Researchers developed novel electron paramagnetic resonance (EPR) brain imaging agents. The five-membered ring derivative, AMCPy, showed potent EPR brain imaging capabilities in mice, unlike other tested compounds.

Area of Science:

  • Medicinal Chemistry
  • Neuroimaging
  • Biomedical Engineering

Background:

  • Developing effective Electron Paramagnetic Resonance (EPR) brain imaging agents is crucial for diagnosing neurological conditions.
  • Existing agents often face challenges with blood-brain barrier (BBB) penetration and retention within the central nervous system (CNS).

Purpose of the Study:

  • To design and synthesize novel acyl-protected hydroxylamine derivatives as potential EPR brain imaging agents.
  • To evaluate the efficacy of these agents in terms of BBB penetration, conversion to detectable radicals, and retention in the brain.
  • To compare the performance of different ring sizes and ester functionalities for EPR brain imaging.

Main Methods:

  • Synthesis of three acyl-protected hydroxylamine derivatives: AMCPe, AMCPy, and DACPy, varying ring size and ester groups.

Related Experiment Videos

  • Assessment of lipophilicity for blood-brain barrier penetration.
  • In vivo evaluation in mice to determine biological relevance and biodistribution patterns.
  • Analysis of conversion to ionic, water-soluble radicals within the brain via esterases and oxidants.

    • Main Results:

    • The synthesized compounds (AMCPe, AMCPy, DACPy) are lipophilic, facilitating BBB penetration.
    • Once in the brain, these derivatives are converted into detectable EPR-active radicals.
    • The five-membered ring derivative, AMCPy, demonstrated potent EPR brain imaging capabilities in mice.
    • The other derivatives, AMCPe and DACPy, were found to be ineffective EPR brain imaging agents.

    Conclusions:

    • Acyl-protected hydroxylamines can serve as effective precursors for EPR brain imaging agents.
    • AMCPy represents a promising candidate for future EPR-based neuroimaging applications.
    • Structural modifications, particularly ring size, significantly influence the efficacy of these imaging agents.